Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Top Cited Papers
- 1 March 2007
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 242 (3), 647-649
- https://doi.org/10.1148/radiol.2423061640
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamideEuropean Radiology, 2006
- Nephrogenic systemic fibrosis: An updateCurrent Rheumatology Reports, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Nephrogenic Systemic Fibrosis: The Nosological and Conceptual Evolution of Nephrogenic Fibrosing DermopathyAmerican Journal of Kidney Diseases, 2005
- Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and TherapySeminars in Dialysis, 2002
- Nephrogenic Fibrosing DermopathyThe American Journal of Dermatopathology, 2001
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000
- Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysisAcademic Radiology, 1998